Quick Answer: iHEAR, a brand of InnerScope Hearing Technologies (OTC: INND), sells two OTC hearing aids: the Xplore (about $499.99/pair, four preset programs, no app) and the aXis (about $799.99–$1,157/pair depending on retailer, app-controlled, dual-microphone directional processing, Receiver-In-Canal fit). Both are FDA-registered for perceived mild-to-moderate hearing loss. iHEAR is sold at CVS and directly at iheardirect.com, and unlike some rival budget OTC brands, its parent company is an actively operating public reporting company rather than one currently winding down U.S. operations. It’s a reasonable budget option, but neither model has independent lab testing from outlets like Soundly or HearingTracker, so weigh that gap against cheaper, lab-verified alternatives like Audien or ELEHEAR before deciding.
iHEAR has quietly become a fixture on pharmacy hearing-aid shelves — this site’s own CVS hearing aids guide lists it among five OTC brands CVS carries — without ever getting its own review here. That’s the same “mentioned everywhere, reviewed nowhere” gap this site closed for Go Hearing. Here’s what iHEAR actually sells, who’s behind it, and where its two models fit against the rest of the budget OTC field.
iHEAR by the numbers
- $499.99 is the retail price for a pair of iHEAR Xplore hearing aids, per Carewell and iHEAR’s own retail listings.
- $799.99 to over $1,157 is the pricing spread for the aXis model across retailers — CVS.com lists it around $799.99, while some medical-supply sites price the same model above $1,150, a wider retailer-to-retailer gap than most OTC brands on this site.
- 24 hours per 2-hour charge, 96 hours total on the go is the battery life InnerScope advertises for the aXis’s magnetic charging case.
- 2021 is the year InnerScope Hearing Technologies (OTC: INND) acquired iHear Medical, folding it into a portfolio that also includes the Hearing Assist brand.
- 43 dB of amplification is the maximum InnerScope advertises for the Xplore’s essential-technology processing.
iHEAR models compared
| Model | Style | App control | Microphones | Price (pair) | Rating |
|---|---|---|---|---|---|
| iHEAR Xplore | Rechargeable, essential tech | No | Single, 4 preset programs | ~$499.99 | ★★★ (not lab-tested) |
| iHEAR aXis | RIC, rechargeable | Yes | Dual, directional | ~$799.99–$1,157 | ★★★½ (not lab-tested) |
| Audien Atom Pro 2 (alt.) | ITE, rechargeable | No | Single | ~$189–$289 | ★★★★ |
| MDHearing VOLT MAX (alt.) | RIC, rechargeable | Yes | Dual | ~$600 | ★★★★ |
1. iHEAR Xplore — The No-App Essential
iHEAR Xplore
- Four preset listening programs — Quiet, Noisy, TV, and Outdoors — switched with a physical button, no smartphone app required.
- Up to 43 dB of amplification aimed at perceived mild-to-moderate hearing loss.
- Rechargeable with a portable charging case, positioned as a straightforward first device for someone who doesn't want to manage an app.
Getting a device shipped and set up doesn’t have to mean waiting around — try Amazon Prime free for 30 days if you’d rather have a backup pair of batteries or a cleaning kit arrive in two days than wait on a slower pharmacy shipment.
2. iHEAR aXis — App-Controlled Directional Sound
iHEAR aXis
- Advanced Directional Dual Microphone speech processing, aimed at improving clarity in moderate-noise settings like restaurants and stores.
- Receiver-In-Canal (RIC) shell for a fuller, less "boxy" sound than typical in-the-ear essential-tech devices.
- Companion smartphone app for adjustments, paired with a compact magnetic snap charging case rated for 24 hours per 2-hour charge, 96 hours total on the go.
- Price varies more than most OTC devices by where you buy it — confirm the current listed price at your retailer of choice before assuming CVS's ~$799.99 is universal.
The aXis is the more interesting of the two models on paper — dual-microphone directional processing is a feature usually reserved for pricier OTC devices, and app control gives more fine-tuning than the Xplore’s four fixed presets. What holds it back from a stronger recommendation is the lack of independent lab data: outlets like Soundly and HearingTracker have run controlled speech-in-noise testing on rivals like Audien, ELEHEAR, and Go Hearing, but not on iHEAR’s lineup as of this writing, so claims about the aXis’s real-world clarity rest on the manufacturer’s own description rather than a verified third-party score.
Who’s behind iHEAR
iHEAR is a brand of InnerScope Hearing Technologies, Inc., which trades over-the-counter under the ticker INND. InnerScope acquired iHear Medical, a direct-to-consumer cloud-based hearing device company, in 2021, gaining access to more than 40 patents along with an FDA-registered manufacturing and R&D facility. InnerScope also owns the Hearing Assist brand and has licensed FDA-cleared self-fitting hearing aid technology from Nuheara for its wider product line.
That corporate structure matters for one reason in particular: several rival budget OTC brands referenced elsewhere on this site — Eargo, Lexie, and Go Hearing — share a parent, LXE Hearing, Inc., that filed to wind down U.S. operations in July 2026. InnerScope is a separate, unrelated company with no connection to that filing, and continues to operate and issue public press releases about new retail partnerships as of 2026. If brand continuity and support availability matter to your purchase decision, iHEAR doesn’t carry that specific risk.
The best alternatives to iHEAR
- Audien Atom Pro 2 (~$189–$289/pair): cheaper than even the Xplore, with independent lab data behind it — see our Audien hearing aids review.
- MDHearing VOLT MAX (~$600/pair): close to aXis pricing with an established U.S. support team — read our MDHearing hearing aids review.
- ELEHEAR Beyond Pro (~$599/pair): independently lab-graded “A” for sound quality — see our ELEHEAR hearing aids review.
- Jabra Enhance Select 300 (~$1,695/pair): if you want remote-audiologist support at aXis-adjacent pricing tiers, see our Jabra Enhance Select 300 review.
- RxEars Rx8 (about $449–$899.99/pair): another CVS-carried option, this one adding a long-range companion microphone instead of directional dual-mic processing — see our RxEars hearing aids review.
For the wider field, see our best cheap hearing aids and best OTC hearing aids roundups. If you’re comparing pharmacy options, our CVS hearing aids guide covers the other four brands sold alongside iHEAR.
Before you buy: the OTC ground rules
iHEAR markets both models as FDA-registered OTC hearing aids for adults with perceived mild-to-moderate hearing loss — a self-assessed category, not a clinical diagnosis. Anyone with severe, sudden, or one-sided hearing loss, ear pain, drainage, or pulsing tinnitus should see a hearing professional rather than starting with any OTC device, iHEAR included.
The bottom line
iHEAR’s Xplore and aXis cover a sensible budget-to-mid range within OTC hearing aids, and the company behind them — InnerScope Hearing Technologies — is a stable, actively operating public company with no continuity risk like some rival budget brands currently carry. The catch is verification: neither model has been through the independent lab testing that Audien, ELEHEAR, and MDHearing have, and aXis pricing swings by several hundred dollars depending on retailer. If you want a lab-verified budget pick, start with Audien or ELEHEAR instead; if iHEAR’s feature set still appeals, buy through CVS or iheardirect.com rather than a pricier third-party medical-supply site. Browse budget hearing aids on Amazon or see our best cheap hearing aids guide for the full field.